EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
Aim. To compare two initial doses (50 or 100mg/day) ofmetoprolol succinate in control released presentation (Betaloc ZOK, AstraZeneca) for achievement of target level of heart rate (HR) in patients with stable course of ischemic heart disease (IHD).Material and methods. 50 patients (34 men and 16 wo...
| Main Authors: | , |
|---|---|
| 格式: | 文件 |
| 语言: | English |
| 出版: |
Столичная издательская компания
2016-01-01
|
| 丛编: | Рациональная фармакотерапия в кардиологии |
| 主题: | |
| 在线阅读: | https://www.rpcardio.online/jour/article/view/1156 |